Cormorant Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Cormorant Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-144,439	Closed	-$4.91M	–	90
2021 Q3	$4.91M	Hold	144,439	–	–	0.2%	68
2021 Q2	$5.29M	Sell	144,439 -55,561	-28%	-$2.15M	0.18%	80
2021 Q1	$8.97M	Hold	200,000	–	–	0.2%	76
2020 Q4	$11.4M	Sell	200,000 -50,000	-20%	-$2.96M	0.27%	61
2020 Q3	$12.8M	Sell	250,000 -68,914	-22%	-$3.38M	0.49%	49
2020 Q2	$19M	Sell	318,914 -31,086	-9%	-$1.66M	0.73%	45
2020 Q1	$14.4M	Sell	350,000 -100,000	-22%	-$5.55M	0.67%	43
2019 Q4	$28M	Sell	450,000 -338,500	-43%	-$16.1M	1.12%	33
2019 Q3	$26.8M	Buy	+788,500	New	+$23.3M	1.63%	21

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cormorant Asset Management's DCPH Position: Q4 2021 in Review

Cormorant Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 144,439 shares — an estimated $4.91M sold.

Cormorant Asset Management first reported a position in DCPH in Q3 2019 and held it in 9 quarters. The position peaked at $28M in Q4 2019. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Cormorant Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Cormorant Asset Management sold 144,439 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $4.91M.
Cormorant Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
Cormorant Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $28M in Q4 2019.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Cormorant Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.